Can Pfizer’s Pipeline Replace Lost COVID Revenue & Patent Cliffs?
Berlin – Pharmaceutical giant Pfizer faces a critical juncture as it navigates a post-COVID revenue landscape and patent expirations. The company is actively reshaping its research and development pipeline, with a renewed focus on oncology, obesity, and other therapeutic areas, including heart failure. This strategic shift aims to ensure sustained growth and innovation in the … Read more